Delivery Order SPE2DB24D1021-SPE2DB25FESHD

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.38 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, with a period of performance through March 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,634.82 firm-fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm-fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,126.91, is a Firm Fixed Price Delivery Order for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,071.66, is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,742.82 firm fixed-price contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medication, with a performance period through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,735.53 firm fixed-price delivery order contract is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical product. The award is not associated with a set-aside program and does not appear to have any major subcontractors. The contract is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,143.73, is a delivery order for the pharmaceutical product DIPRIVAN 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of October 26, 2023 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical care medication. The $6,771.10 firm-fixed-price delivery order has a completion date of July 30, 2024 and is not designated as a set-aside contract. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of...
This is a $2,161.86 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity, to support military healthcare programs. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESHD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.20 firm-fixed-price delivery order is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical product, with a performance period through December 3, 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, running through November 2026, encompasses a wide array of critical medical commodities across multiple therapeutic areas. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:48 PM